相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of fluoroquinolone prophylaxis during neutropenia on bloodstream infection: Data from a surveillance program in 8755 patients receiving high-dose chemotherapy for haematologic malignancies between 2009 and 2014
Winfried Kern et al.
JOURNAL OF INFECTION (2018)
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines
Malgorzata Mikulska et al.
JOURNAL OF INFECTION (2018)
Antimicrobial Resistance
Hilary D. Marston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis
Chun-Wei Wu et al.
SUPPORTIVE CARE IN CANCER (2015)
Clinical and Microbiological Profile of Pathogens in Febrile Neutropenia in Hematological Malignancies: A Single Center Prospective Analysis
M. Taj et al.
JOURNAL OF ONCOLOGY (2015)
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
Christopher R. Flowers et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients
Marketa Markova et al.
SUPPORTIVE CARE IN CANCER (2013)
Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center
Arun B. Karanwal et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2013)
Prevention and Treatment of Cancer-Related Infections
Lindsey Robert Baden et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
Use of antibacterial prophylaxis for patients with neutropenia
M. A. Slavin et al.
INTERNAL MEDICINE JOURNAL (2011)
Biomarkers for bacteremia and severe sepsis in hematological patients with neutropenic fever: multivariate logistic regression analysis and factor analysis
Auni Juutilainen et al.
LEUKEMIA & LYMPHOMA (2011)
Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network
Edwin Pun Hui et al.
SUPPORTIVE CARE IN CANCER (2011)
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: Results of a single institution, randomized phase 2 trial
Evangelos Eleutherakis-Papaiakovou et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Management of febrile neutropenia: ESMO Clinical Practice Guidelines
J. de Naurois et al.
ANNALS OF ONCOLOGY (2010)
Prediction of outcome in cancer patients with febrile neutropenia:: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6, -8 and -10
A. Uys et al.
EUROPEAN JOURNAL OF CANCER CARE (2007)
Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients
Giampaolo Bucaneve et al.
EJC SUPPLEMENTS (2007)
Antibiotic prophylaxis in neutropenic patients - New evidence, practical decisions
Leonard Leibovici et al.
CANCER (2006)
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
G Bucaneve et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Epidemiology and risk factors for extended-spectrum β-lactamase-producing organisms:: A case control study at a tertiary care center in Lebanon
ZA Kanafani et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2005)
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay
KA Marr et al.
CLINICAL INFECTIOUS DISEASES (2005)
Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility
G Mendelson et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients
R Colodner et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2004)
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for infection and impact of resistance on outcomes
E Lautenbach et al.
CLINICAL INFECTIOUS DISEASES (2001)
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients
J Klastersky et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
